T1DM is a typical organ-specific disease characterized by immune-mediated destruction of insulin-producing β cells in pancreatic islets (171), resulting in the loss of control of blood glucose levels even with insulin replacement therapy; this can in turn lead to ketoacidosis, severe hypoglycemia, and secondary complications (172). The gene discussed is INS; the disease is Hypoglycemia.